Search

Your search keyword '"Ogata, T"' showing total 52 results

Search Constraints

Start Over You searched for: Author "Ogata, T" Remove constraint Author: "Ogata, T" Topic adenocarcinoma Remove constraint Topic: adenocarcinoma
52 results on '"Ogata, T"'

Search Results

1. Can Clinical Stage in the 8 th Edition of the Union for International Cancer Control TNM Classification Stratify the Prognosis of Patients Undergoing Curative Surgery for Siewert Type II/III Adenocarcinoma of the Esophagogastric Junction?

2. Nivolumab versus irinotecan as third- or later-line treatment for advanced gastric cancer: a multi-center retrospective study.

3. Should the splenic hilar lymph node be dissected for the management of adenocarcinoma of the esophagogastric junction?

4. First-line pembrolizumab + chemotherapy in Japanese patients with advanced/metastatic esophageal cancer from KEYNOTE-590.

5. Predictive and Prognostic Value of SUOX Expression in Pancreatic Ductal Adenocarcinoma.

6. Second-line Chemotherapy for Previously Treated Metastatic Small Bowel Adenocarcinoma: A Retrospective Analysis.

7. Is sufficient experience performing open gastrectomies necessary to start laparoscopic distal gastrectomy training?

8. Clinical Significance of Stanniocalcin2 mRNA Expression in Patients With Colorectal Cancer.

9. The Impact of Severe Infectious Complications on Long-term Prognosis for Gastric Cancer.

10. Risk factors analysis and stratification for microscopically positive resection margin in gastric cancer patients.

11. Impact of the ESM-1 Gene Expression on Outcomes in Stage II/III Gastric Cancer Patients Who Received Adjuvant S-1 Chemotherapy.

12. [Local Resection of Gastric Tube Cancer with a Gastrointestinal Endoscope].

13. Risk factors for severe weight loss at 1 month after gastrectomy for gastric cancer.

14. Priority of lymph node dissection for proximal gastric cancer invading the greater curvature.

15. [Three Cases of Adenocarcinoma of the Advanced Esophago-Gastric Junction Confirmed as Pathological Complete Response Following Neoadjuvant Chemotherapyand Gastrectomy].

16. [Case of Colon Metastasis from Early Gastric Cancer 4 Years after Laparoscopic Assisted Distal Gastrectomy].

17. [A Case of HER2-Positive Siewert Type I Adenocarcinoma of the Esophagogastric Junction Treated via Neoadjuvant Chemotherapy Followed by Radical Resection].

18. [A Case of Synchronous Esophageal and Gastric Cancer Successfully Treated Using Multimodal Therapy].

19. Impact of preoperative hand grip strength on morbidity following gastric cancer surgery.

20. Risk Factors for the Loss of Lean Body Mass After Gastrectomy for Gastric Cancer.

21. Loss of Lean Body Mass as an Independent Risk Factor for Continuation of S-1 Adjuvant Chemotherapy for Gastric Cancer.

22. A New Statistical Model Identified Two-thirds of Clinical T1 Gastric Cancers as Possible Candidates for Endoscopic Treatment.

23. Impact of infectious complications on gastric cancer recurrence.

24. A methylene blue-assisted technique for harvesting lymph nodes after radical surgery for gastric cancer: a prospective, randomized, controlled study.

25. [The case of a solitary pulmonary tumor which could be diagnosed as early gastric cancer recurrence by detailed pathological examinations].

26. Diagnostic value of computed tomography for staging of clinical T1 gastric cancer.

27. Risk factors for 6-month continuation of S-1 adjuvant chemotherapy for gastric cancer.

28. Pathological complete response of locally advanced gastric cancer after four courses of neoadjuvant chemotherapy with paclitaxel plus cisplatin: report of a case.

29. Severity of complications after gastrectomy in elderly patients with gastric cancer.

30. Survival and prognosticators of gastric cancer that recurs after adjuvant chemotherapy with S-1.

31. Carbon ion irradiation suppresses metastatic potential of human non-small cell lung cancer A549 cells through the phosphatidylinositol-3-kinase/Akt signaling pathway.

32. Significance of thymidylate synthase gene expression level in patients with adenocarcinoma of the lung.

33. [A case of gastric cancer with multiple liver metastases effectively treated by hepatic arterial infusion of MMC, TS-1/CDDP therapy, and thermotherapy].

34. Expression of alpha-smooth muscle actin in small bronchioloalveolar adenocarcinoma of the lung: assessment and comparison with noguchi criteria.

35. Gene expression of granulocyte colony stimulating factor (G-CSF) in non-small cell lung cancer.

36. Colorectal carcinoma metastatic to skeletal muscle.

37. Immunohistochemical analysis of cathepsin B expression in human lung adenocarcinoma: the role in cancer progression.

38. [Complete resection of left apical invading lung cancer, following reconstruction of subclavian artery by artificial graft--a case report].

39. Scanning electron microscopic study of the collagen networks of the normal mucosa, hyperplastic polyps, tubular adenoma, and adenocarcinoma of the human large intestine.

40. [Histopathological evaluation of the radiosensitizing effects of an intratumoral injection of BrdU for rectal cancer].

41. [Surgical treatment of pathological stage III and IV in non-small cell lung cancer with peripheral tumor of 3 cm or less in diameter].

42. [Right sleeve pneumonectomy after bronchial arterial infusion in lung cancer].

44. [Postoperative chemotherapy of pathological stage I non-small cell carcinoma of the lung].

45. [Carinal resection associated with subtotal esophagectomy ofa carcinoma of the esophagus with an esophagotracheal fistula].

46. Clara cell granules of peripheral lung cancers.

48. [A case of simultaneous surgery for primary double cancer of the stomach and kidney].

49. [Three cases of panpleuro-pneumonectomy with intrapleural BCG for the treatment of advanced lung cancer (author's transl)].

50. [Adenocarcinoma of the esophagus (early stage) concomitant with lung cancer--a case report].

Catalog

Books, media, physical & digital resources